Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Sachdev Amit
Relationship:  
City:   Cambridge
State:   MA
   
Insider Summary:
  
   
Companies Owned :   2    
Direct Shares   71,325    

Indirect Shares

  7,447      
Direct Value   $26,276,609    

Indirect Value

  $3,536,953      
Total Shares   78,772      
Total Value   $29,813,561      


Vertex Pharmaceuticals Inc
 $26,276,609 Celladon Corp
 $0 Vertex Pharmaceuticals Inc
 $26,276,609 Celladon Corp
 $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    0    

     Stock price went up :

    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Vertex Pharmaceuticals Inc VRTX EVP Chief Patient & Ex... 2024-05-15 55,325 2024-05-15 7,447    Premium*  
            Celladon Corp CLDN 2022-03-11 16,000 2020-03-12 0    Premium*  
* Premium Members only  

Records found :    193         Free Registration Required For Full Results.    Limit: 25

Download
  Page 3 of 8
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
VRTX Vertex Pharmaceuticals In... EVP, Policy, Access & Value   •       –      –    2014-11-28 4 OE $39.05 $468,600 D/D 12,000 90,671 0 -
VRTX Vertex Pharmaceuticals In... EVP, Policy, Access & Value   •       –      –    2015-01-09 4 OE $39.05 $468,600 D/D 12,000 90,671 0 -
VRTX Vertex Pharmaceuticals In... EVP, Policy, Access & Value   •       –      –    2015-03-18 4 OE $39.05 $508,748 D/D 12,000 101,984 0 -
VRTX Vertex Pharmaceuticals In... SVP, Corp Affairs & Pub Policy   •       –      –    2011-01-18 4 AS $39.50 $624,685 D/D (15,664) 36,088 0 -
VRTX Vertex Pharmaceuticals In... SVP, Corp Affairs & Pub Policy   •       –      –    2011-01-21 4 AS $39.92 $84,950 D/D (2,128) 33,960 0 -
VRTX Vertex Pharmaceuticals In... SVP, Corp Affairs & Pub Policy   •       –      –    2012-03-30 4 AS $41.01 $1,089,308 D/D (26,562) 33,608 0 -
VRTX Vertex Pharmaceuticals In... SVP, Corp Affairs & Pub Policy   •       –      –    2012-11-16 4 AS $41.29 $94,430 D/D (2,287) 18,821 0 -
VRTX Vertex Pharmaceuticals In... SVP, Corp Affairs & Pub Policy   •       –      –    2011-02-23 4 AS $43.60 $1,043,666 D/D (23,828) 44,126 0 -
VRTX Vertex Pharmaceuticals In... SVP, Corp Affairs & Pub Policy   •       –      –    2011-02-28 4 AS $45.00 $726,830 D/D (15,887) 40,154 0 -
VRTX Vertex Pharmaceuticals In... EVP, Policy, Access & Value   •       –      –    2015-03-20 4 OE $45.11 $546,649 D/D 12,000 101,984 0 -
VRTX Vertex Pharmaceuticals In... SVP, Corp Affairs & Pub Policy   •       –      –    2011-03-03 4 AS $49.50 $471,785 D/D (9,531) 40,154 0 -
VRTX Vertex Pharmaceuticals In... SVP, Corp Affairs & Pub Policy   •       –      –    2011-07-25 4 AS $49.66 $74,882 D/D (1,500) 39,074 0 -
VRTX Vertex Pharmaceuticals In... EVP, CRO   •       –      –    2017-06-01 4 OE $51.75 $1,578,375 D/D 30,500 129,835 0 -
VRTX Vertex Pharmaceuticals In... SVP, Corp Affairs & Pub Policy   •       –      –    2012-05-07 4 AS $52.13 $3,062,638 D/D (58,750) 31,108 0 -
VRTX Vertex Pharmaceuticals In... SVP, Corp Affairs & Pub Policy   •       –      –    2012-09-13 4 AS $55.86 $2,150,304 D/D (38,281) 21,108 0 -
VRTX Vertex Pharmaceuticals In... SVP, Corp Affairs & Pub Policy   •       –      –    2012-09-14 4 AS $58.00 $552,798 D/D (9,531) 21,108 0 -
VRTX Vertex Pharmaceuticals In... SVP, Corp Affairs & Pub Policy   •       –      –    2012-09-21 4 AS $59.00 $562,329 D/D (9,531) 21,108 0 -
VRTX Vertex Pharmaceuticals In... SVP, Global Gov. Strategy   •       –      –    2013-12-12 4 AS $65.47 $166,425 D/D (2,542) 26,561 0 -
VRTX Vertex Pharmaceuticals In... EVP, CRO   •       –      –    2017-07-19 4 OE $77.31 $1,546,200 D/D 20,000 119,335 0 -
VRTX Vertex Pharmaceuticals In... EVP, CRO   •       –      –    2018-01-19 4 OE $77.31 $2,589,732 D/D 32,422 71,585 0 -
VRTX Vertex Pharmaceuticals In... EVP, CRO   •       –      –    2018-02-05 4 OE $77.31 $367,327 D/D 4,520 43,683 0 -
VRTX Vertex Pharmaceuticals In... SVP, Global Gov. Strategy   •       –      –    2013-07-05 4 AS $80.65 $5,030,805 D/D (61,907) 28,987 0 -
VRTX Vertex Pharmaceuticals In... EVP, Policy, Access & Value   •       –      –    2016-05-16 4 AS $81.67 $9,555 D/D (117) 86,096 0 -
VRTX Vertex Pharmaceuticals In... EVP, CRO   •       –      –    2018-01-22 4 OE $83.36 $1,146,200 D/D 13,750 52,913 0 -
VRTX Vertex Pharmaceuticals In... SVP, Global Gov. Strategy   •       –      –    2013-07-11 4 AS $84.00 $588,000 D/D (7,000) 28,987 0 -

  193  Records found
  1   2   3  4   5   6   7   8      
  Page 3 of 8  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed